Medplus Health Services Share Price Today | Stock Price & Medplus Health Services Share Screener
As of October 5, 2026, the live Medplus Health Services share price (NSE: MEDPLUS) is ₹644.40 on NSE and ₹643.95 on BSE, down 1.51% from the previous close, with shares trading between ₹640.10 and ₹655.55 in today's trading session, and a 52-week range of ₹644.40–₹953.90. Check MEDPLUS price range for the annual price range and momentum. Use the Medplus Health Services stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Medplus Health Services opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹1,885 and net income of ₹64, with EBITDA of ₹190, an operating margin of 9.0% and a profit margin of 3.4%.
Medplus Health Services Share Price Chart
Track the current stock price of Medplus Health Services with an interactive chart. Analyse MEDPLUS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Medplus Health Services stock quote in one place.
The quote of ₹644.40 sits between the 52-week low of ₹644.40 and the 52-week high of ₹953.90, and the latest session moved -1.51% from the previous close.
Medplus Health Services Company Profile - Fundamental Screener
Screen Medplus Health Services company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDPLUS shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Retail sector and the Pharmacy Retail industry, and it trades under ISIN INE804L01022.
Company Details
Classification
Identifiers and Leadership
Medplus Health Services Balance Sheet Screener
Screen MEDPLUS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹3,933, up from ₹3,360 in 2025.
Latest statistics put total assets at ₹3,933 and shareholder funds at ₹1,975, with a leverage ratio of 0.68.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 3,933 | 3,360 | 3,005 | 2,797 | 2,594 | 1,566 | 1,349 | 673 | 644 | 538 |
| Current Assets | 2,069 | 1,844 | 1,568 | 1,481 | 1,632 | 923 | 816 | 475 | 458 | 397 |
| Fixed Assets | 1,595 | 1,296 | 1,242 | 1,138 | 799 | 517 | 420 | 90 | 84 | 81 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,269 | 1,044 | 902 | 830 | 618 | 420 | 339 | 11 | 15 | 111 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 1,975 | 1,740 | 1,577 | 1,491 | 1,417 | 731 | 529 | 325 | 304 | 149 |
| Share Capital | 24 | 24 | 24 | 24 | 24 | 0 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 1,951 | 1,717 | 1,554 | 1,467 | 1,394 | 359 | 528 | 325 | 303 | 149 |
Medplus Health Services Income Statement Screener - Profit & Revenue Analysis
Screen Medplus Health Services income statement and profit fundamentals. Analyze MEDPLUS quarterly results. Medplus Health Services reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹1,885 and net profit was ₹64, equal to earnings per unit of ₹5.33, at an operating margin of 9%.
In that period expenses were ₹1,695, interest cost ₹34 and tax ₹16. The next period listed, 2026-Jun, shows revenue of ₹1,899 and net profit of ₹33.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 1,885 | 1,899 | 1,525 | 1,558 | 1,697 | 1,824 | 1,501 | 1,498 | 1,588 | 1,574 | 1,267 | 1,294 | 1,419 | 1,451 | 979 |
| Expenses | 1,695 | 1,746 | 1,373 | 1,412 | 1,531 | 1,648 | 1,385 | 1,395 | 1,452 | 1,429 | 1,171 | 1,213 | 1,324 | 1,350 | 914 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 190 | 153 | 152 | 146 | 166 | 177 | 116 | 103 | 136 | 145 | 95 | 81 | 96 | 102 | 65 |
| Operating Profit % | 9.00% | 7.00% | 9.00% | 8.00% | 9.00% | 9.00% | 7.00% | 6.00% | 8.00% | 8.00% | 7.00% | 6.00% | 6.00% | 6.00% | 5.00% |
| Depreciation | 76 | 78 | 64 | 66 | 69 | 73 | 59 | 60 | 63 | 63 | 56 | 52 | 56 | 57 | 34 |
| Interest | 34 | 33 | 27 | 27 | 29 | 31 | 25 | 25 | 25 | 26 | 22 | 23 | 24 | 25 | 19 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 80 | 42 | 61 | 53 | 69 | 73 | 32 | 18 | 48 | 57 | 17 | 5 | 16 | 20 | 13 |
| Tax | 16 | 9 | 10 | 10 | 13 | 16 | -2 | 4 | 9 | 11 | -9 | 1 | 2 | 6 | 1 |
| Net Profit | 64 | 33 | 51 | 42 | 56 | 58 | 34 | 14 | 39 | 46 | 27 | 4 | 15 | 14 | 11 |
| EPS | 5.33 | 2.76 | 4.32 | 3.54 | 4.63 | 4.82 | 2.81 | 1.20 | 3.24 | 3.84 | 2.24 | 0.32 | 1.22 | 1.15 | 0.99 |
Medplus Health Services Cash Flow Screener - Liquidity Fundamentals
Screen MEDPLUS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹496, and net cash flow was an inflow of ₹112.
Over the same period, investing activities used ₹128 and financing activities used ₹256.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 496 | 540 | 144 | 90 | 170 | 3 | -7 | 147 | 32 | 34 |
| Investing Activities | -128 | -318 | -83 | 429 | -703 | -35 | -28 | -19 | -18 | -15 |
Financing and Net Cash | ||||||||||
| Financing Activities | -256 | -228 | -198 | -170 | 440 | -6 | 90 | -83 | -1 | -29 |
| Net Cash Flow | 112 | -5 | -137 | 350 | -93 | -37 | 56 | 45 | 14 | -10 |
Medplus Health Services Shareholding Pattern Screener
See Medplus Health Services shareholding pattern with promoter, FII, and DII holdings. Check Medplus Health Services promoter holding and ownership changes for MEDPLUS on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 40.22%, foreign institutions 15.53%, domestic institutions 27.82% and the public 11.82%, spread across 77,278 shareholders.
The shareholder count was 77,278 in 2026-Mar, compared with 76,005 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 40.22% | 40.19% | 40.34% | 40.32% | 40.29% | 40.29% | 40.39% | 40.39% |
Institutional Investors | ||||||||
| FII Holding | 15.53% | 14.38% | 15.61% | 16.42% | 16.54% | 16.83% | 14.94% | 14.85% |
| DII Holding | 27.82% | 29.95% | 26.19% | 26.04% | 26.52% | 26.57% | 22.47% | 22.17% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.82% | 10.90% | 13.10% | 12.59% | 12.22% | 11.88% | 7.30% | 7.56% |
| Other Holding | 4.62% | 4.58% | 4.77% | 4.64% | 4.43% | 4.42% | 14.90% | 15.03% |
| Shareholder Count | 77,278 | 76,005 | 83,439 | 81,742 | 78,337 | 79,157 | 74,976 | 76,934 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Medplus Health Services. Medplus Health Services dividend yield can be compared with peers and other stocks in the market.
Medplus Health Services Stock Index Membership - Nifty & Sensex
See which indices include Medplus Health Services stock. Check MEDPLUS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 9 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE Consumer Discretionary Index, BSE INDEX BSE500, BSE INDEX MSL400.
Complete Index List
Medplus Health Services Market Events Screener - Corporate Actions
Get Medplus Health Services corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Medplus Health Services stock events that may affect MEDPLUS share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated August 17, 2026, with a record date of August 17, 2026.
It is followed by Quarterly Result Announcement dated July 21, 2026 and Quarterly Result Announcement dated May 20, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-17 | 2026-08-17 | Annual General Meeting | NA | -15.92% |
| 2026-07-21 | 2026-07-21 | Quarterly Result Announcement | NA | -2.54% |
| 2026-05-20 | 2026-05-20 | Quarterly Result Announcement | NA | 12.99% |
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | -4.45% |
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 0.05% |
| 2025-09-15 | 2025-09-15 | Annual General Meeting | NA | -8.36% |
| 2025-08-02 | 2025-08-02 | Quarterly Result Announcement | NA | 7.22% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | 33.44% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -13.83% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 3.71% |
| 2024-09-26 | 2024-09-26 | Annual General Meeting | NA | 1.08% |
| 2023-12-15 | 2023-12-15 | Extraordinary General Meeting | NA | -9.69% |
Medplus Health Services Competitors Screener - Peer Stocks Comparison
Screen MEDPLUS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 4 companies in the Retail sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Medplus Health Services | 7,857 | 37.06 | 6,964 | 12.60% | 220 | 41.25 |
| Entero Healthcare Solutions | 7,681 | 46.53 | 6,610 | 28.72% | 146 | 54.51 |
| Trimurthi | 199 | 9 | -4.17% | -2 | 35.07 | |
| Vijaypd Ceutical | 129 | 25.78 | 104 | 1.98% | 5 | 50.17 |
Medplus Health Services Company Announcements - News & Reports Screener
Screen MEDPLUS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 4, 2026.
The next most recent announcements are dated October 4, 2026 and September 10, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-04 | Closure of Trading Window | - |
| 2026-10-04 | Board Meeting Intimation for The Quarter And Half-Year Ended September 30 2026. | - |
| 2026-09-10 | Board Comments On Fine Levied By The Exchange | - |
| 2026-09-10 | Board Meeting Outcome for Outcome Of Board Meeting Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) | - |
| 2026-08-26 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-26 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-21 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-21 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-18 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-17 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-06 | Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-05 | Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-01 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-31 | Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-29 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-29 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-29 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-29 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹644.40, within a 52-week range of ₹644.40 to ₹953.90. The P/E ratio is 37.06 and the P/B ratio is 3.95, with earnings per unit of ₹18.33. Market capitalisation stands at ₹7,856.96 Cr. The company operates in the Retail sector, in the Pharmacy Retail industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.